SCHEMBL3267237

SCHEMBL3267237

C=CCC1CC(=O)[N]C1=O

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.35
NOS1 P29475 2/20 0.34
NOS2 P35228 2/20 0.34
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10937495 0.80 NOS1 (0.36) FAAHNOS1NOS2
SCHEMBL3271573 0.71
SCHEMBL10806119 0.68
SCHEMBL3265923 0.68 NOS1 (0.31) NOS1NOS2
SCHEMBL7744945 0.68 ALDH1A1 (0.57) FAAHALDH1A1
SCHEMBL3266225 0.67
SCHEMBL3267353 0.67 MME (0.36)
SCHEMBL6402909 0.66 FAAH (0.40) FAAHNOS1NOS2ALDH1A1
SCHEMBL3267280 0.64
SCHEMBL6260486 0.64 CYP1A2 (0.40) NOS1NOS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4578474-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1986-03-25 US claimed
EP-0042639-B1 AZIDO, IMIDO, AMIDO AND AMINO DERIVATIVES OF MERCAPTOACYL PROLINES AND PIPECOLIC ACIDS HAVING HYPOTENSIVE ACTIVITY E.R. Squibb & Sons, Inc. (US) 1984-08-22 EP claimed
US-4454225-A COUPLERS PREVENTING YELLOW IDSCOLORATION AT UNEXPOSED AREAS FUJI PHOTO FILM CO., LTD. (JP) 1984-06-12 US claimed
EP-0042639-A2 Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity E.R. Squibb & Sons, Inc. (US) 1981-12-30 EP claimed
EP-1517881-B1 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2010-06-02 EP disclosed
US-7414064-B2 4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives SYNGENTA CROP PROTECTION, INC. (US) 2008-08-19 US disclosed
CN-100372849-C Pyrrolopyrimidines as cysteine protease inhibitors NOVARTIS AG (CH) 2008-03-05 CN disclosed
US-20070142445-A1 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives SYNGENTA CROP PROTECTION, INC. (US) 2007-06-21 US disclosed
US-7192965-B2 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives SYNGENTA CROP PROTECTION, INC. (US) 2007-03-20 US disclosed
US-20050272649-A1 Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure STRYKER CORPORATION 2005-12-08 US disclosed
US-20050245583-A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives SYNGENTA CROP PROTECTION, INC. 2005-11-03 US disclosed
EP-1578360-A2 CONJOINT ADMINISTRATION OF MORPHOGENS AND ACE INHIBITORS IN TREATMENT OF CHRONIC RENAL FAILURE Curis, Inc. (US) 2005-09-28 EP disclosed
US-4578474-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1986-03-25 US disclosed
US-4497953-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1985-02-05 US disclosed
EP-0042639-B1 AZIDO, IMIDO, AMIDO AND AMINO DERIVATIVES OF MERCAPTOACYL PROLINES AND PIPECOLIC ACIDS HAVING HYPOTENSIVE ACTIVITY E.R. Squibb & Sons, Inc. (US) 1984-08-22 EP disclosed
US-4454225-A COUPLERS PREVENTING YELLOW IDSCOLORATION AT UNEXPOSED AREAS FUJI PHOTO FILM CO., LTD. (JP) 1984-06-12 US disclosed
US-4390695-A HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1983-06-28 US disclosed
US-4310461-A HYPTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1982-01-12 US disclosed
EP-0042639-A2 Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity E.R. Squibb & Sons, Inc. (US) 1981-12-30 EP disclosed
EP-0042639-A2 Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity E.R. Squibb & Sons, Inc. (US) 1981-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272649-A1 Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure BMPR2, BMP2, BMP1 FAAH 1346/4885NOS1 1435/4885NOS2 832/4885
US-20050245583-A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives DDT, RER1, SCN7A FAAH 2459/4885NOS1 577/4885NOS2 1002/4885
US-20070142445-A1 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives DDT, RER1, SCN7A FAAH 2459/4885NOS1 577/4885NOS2 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.